283 related articles for article (PubMed ID: 21266721)
1. Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation.
Smedley RC; Spangler WL; Esplin DG; Kitchell BE; Bergman PJ; Ho HY; Bergin IL; Kiupel M
Vet Pathol; 2011 Jan; 48(1):54-72. PubMed ID: 21266721
[TBL] [Abstract][Full Text] [Related]
2. Recommended guidelines for the conduct and evaluation of prognostic studies in veterinary oncology.
Webster JD; Dennis MM; Dervisis N; Heller J; Bacon NJ; Bergman PJ; Bienzle D; Cassali G; Castagnaro M; Cullen J; Esplin DG; Peña L; Goldschmidt MH; Hahn KA; Henry CJ; Hellmén E; Kamstock D; Kirpensteijn J; Kitchell BE; Amorim RL; Lenz SD; Lipscomb TP; McEntee M; McGill LD; McKnight CA; McManus PM; Moore AS; Moore PF; Moroff SD; Nakayama H; Northrup NC; Sarli G; Scase T; Sorenmo K; Schulman FY; Shoieb AM; Smedley RC; Spangler WL; Teske E; Thamm DH; Valli VE; Vernau W; von Euler H; Withrow SJ; Weisbrode SE; Yager J; Kiupel M;
Vet Pathol; 2011 Jan; 48(1):7-18. PubMed ID: 20664014
[TBL] [Abstract][Full Text] [Related]
3. Expression of monocarboxylate transporter 1 in oral and ocular canine melanocytic tumors.
Shimoyama Y; Akihara Y; Kirat D; Iwano H; Hirayama K; Kagawa Y; Ohmachi T; Matsuda K; Okamoto M; Kadosawa T; Yokota H; Taniyama H
Vet Pathol; 2007 Jul; 44(4):449-57. PubMed ID: 17606506
[TBL] [Abstract][Full Text] [Related]
4. Prognostic evaluation of Ki67 threshold value in canine oral melanoma.
Bergin IL; Smedley RC; Esplin DG; Spangler WL; Kiupel M
Vet Pathol; 2011 Jan; 48(1):41-53. PubMed ID: 21123859
[TBL] [Abstract][Full Text] [Related]
5. The histologic and epidemiologic bases for prognostic considerations in canine melanocytic neoplasia.
Spangler WL; Kass PH
Vet Pathol; 2006 Mar; 43(2):136-49. PubMed ID: 16537931
[TBL] [Abstract][Full Text] [Related]
6. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
Roels S; Tilmant K; Ducatelle R
J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
[TBL] [Abstract][Full Text] [Related]
7. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
[TBL] [Abstract][Full Text] [Related]
8. Classification of canine malignant lymphomas according to the World Health Organization criteria.
Valli VE; San Myint M; Barthel A; Bienzle D; Caswell J; Colbatzky F; Durham A; Ehrhart EJ; Johnson Y; Jones C; Kiupel M; Labelle P; Lester S; Miller M; Moore P; Moroff S; Roccabianca P; Ramos-Vara J; Ross A; Scase T; Tvedten H; Vernau W
Vet Pathol; 2011 Jan; 48(1):198-211. PubMed ID: 20861499
[TBL] [Abstract][Full Text] [Related]
9. Development, anatomy, histology, lymphatic drainage, clinical features, and cell differentiation markers of canine mammary gland neoplasms.
Sorenmo KU; Rasotto R; Zappulli V; Goldschmidt MH
Vet Pathol; 2011 Jan; 48(1):85-97. PubMed ID: 21147765
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation.
Sánchez J; Ramirez GA; Buendia AJ; Vilafranca M; Martinez CM; Altimira J; Navarro JA
Vet Pathol; 2007 Sep; 44(5):676-82. PubMed ID: 17846240
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical diagnosis of canine oral amelanotic melanocytic neoplasms.
Smedley RC; Lamoureux J; Sledge DG; Kiupel M
Vet Pathol; 2011 Jan; 48(1):32-40. PubMed ID: 21078882
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of versican and hyaluronan in melanocytic tumors of dogs.
Docampo MJ; Rabanal RM; Miquel-Serra L; Hernández D; Domenzain C; Bassols A
Am J Vet Res; 2007 Dec; 68(12):1376-85. PubMed ID: 18052744
[TBL] [Abstract][Full Text] [Related]
13. Canine astrocytic tumors: a comparative review.
Stoica G; Levine J; Wolff J; Murphy K
Vet Pathol; 2011 Jan; 48(1):266-75. PubMed ID: 21059873
[TBL] [Abstract][Full Text] [Related]
14. Canine limbal melanoma: 30 cases (1992-2004). Part 1. Signalment, clinical and histological features and pedigree analysis.
Donaldson D; Sansom J; Scase T; Adams V; Mellersh C
Vet Ophthalmol; 2006; 9(2):115-9. PubMed ID: 16497236
[TBL] [Abstract][Full Text] [Related]
15. Recommended guidelines for submission, trimming, margin evaluation, and reporting of tumor biopsy specimens in veterinary surgical pathology.
Kamstock DA; Ehrhart EJ; Getzy DM; Bacon NJ; Rassnick KM; Moroff SD; Liu SM; Straw RC; McKnight CA; Amorim RL; Bienzle D; Cassali GD; Cullen JM; Dennis MM; Esplin DG; Foster RA; Goldschmidt MH; Gruber AD; Hellmén E; Howerth EW; Labelle P; Lenz SD; Lipscomb TP; Locke E; McGill LD; Miller MA; Mouser PJ; O'Toole D; Pool RR; Powers BE; Ramos-Vara JA; Roccabianca P; Ross AD; Sailasuta A; Sarli G; Scase TJ; Schulman FY; Shoieb AM; Singh K; Sledge D; Smedley RC; Smith KC; Spangler WL; Steficek B; Stromberg PC; Valli VE; Yager J; Kiupel M;
Vet Pathol; 2011 Jan; 48(1):19-31. PubMed ID: 21123864
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of tenascin in melanocytic tumours of dogs.
Sevastre B; van Ederen AM; Terlou M; Gruys E; Nederbragt H
J Comp Pathol; 2007 Jan; 136(1):49-56. PubMed ID: 17258226
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and histopathologic prognostication of canine melanocytic neoplasms: A consensus of the Oncology-Pathology Working Group.
Smedley RC; Bongiovanni L; Bacmeister C; Clifford CA; Christensen N; Dreyfus JM; Gary JM; Pavuk A; Rowland PH; Swanson C; Tripp C; Woods JP; Bergman PJ
Vet Comp Oncol; 2022 Dec; 20(4):739-751. PubMed ID: 35522017
[TBL] [Abstract][Full Text] [Related]
18. The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours.
Ferreira E; Bertagnolli AC; Cavalcanti MF; Schmitt FC; Cassali GD
Vet Comp Oncol; 2009 Dec; 7(4):230-5. PubMed ID: 19891693
[TBL] [Abstract][Full Text] [Related]
19. Mast cells and angiogenesis in canine melanomas: malignancy and clinicopathological factors.
Mukaratirwa S; Chikafa L; Dliwayo R; Moyo N
Vet Dermatol; 2006 Apr; 17(2):141-6. PubMed ID: 16515657
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of CD44 in canine melanocytic tumours.
Serra M; Rabanal RM; Miquel L; Domenzain C; Bassols A
J Comp Pathol; 2004; 130(2-3):171-80. PubMed ID: 15003475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
